EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease

European Heart Journal

Volumn 32, Issue 17, 2011, Pages 2189-2214

  Zamorano, Jose L ^a   Badano, Luigi P ^b   Bruce, Charles ^c   Chan, Kwan Leung ^d   Gonalves, Alexandra ^e   Hahn, Rebecca T ^f   Keane, Martin G ^g   La Canna, Giovanni ^h   Monaghan, Mark J ⁱ   Nihoyannopoulos, Petros ^j   Silvestry, Frank E ^g   Vanoverschelde, Jean Louis ^k   Gillam, Linda D ^l  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b UNIVERSITY OF PADOVA   (Italy)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^e UNIVERSITY OF PORTO   (Portugal)

^f NewYork Presbyterian Hospital   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h SAN RAFFAELE HOSPITAL   (Italy)

ⁱ KING'S COLLEGE LONDON   (United Kingdom)

^j HAMMERSMITH HOSPITAL   (United Kingdom)

^k CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^l Gagnon Cardiovascular Institute   (United States)

more..

Author keywords

Echocardiography; Transcatheter aortic valve implantation; Transcatheter mitral repair; Transcatheter paravalvular leak closure

Indexed keywords

ANGIOGRAPHY; AORTA STENOSIS; AORTA VALVE PROSTHESIS; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; AORTIC VALVE REPAIR; ARTICLE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FLUOROSCOPY; FOLLOW UP; HEART CATHETERIZATION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE FAILURE; HEART TAMPONADE; HEART VALVE PROSTHESIS; HEART VENTRICLE REMODELING; HUMAN; MEDICAL SOCIETY; MITRAL ANNULOPLASTY; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PERICARDIAL EFFUSION; PERIOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTHESIS FAILURE; QUALITY OF LIFE; SURGICAL APPROACH; SURGICAL RISK; SURVIVAL RATE; THREE DIMENSIONAL ECHOCARDIOGRAPHY; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSLUMINAL VALVULOPLASTY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME; TWO DIMENSIONAL ECHOCARDIOGRAPHY; VALVULAR HEART DISEASE;

AORTIC VALVE; AORTIC VALVE STENOSIS; ECHOCARDIOGRAPHY; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PATIENT SELECTION; PROSTHESIS DESIGN; STENTS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 80052572953     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehr259     Document Type: Article

References (80)

1. Silvestry FE, Kerber RE, Brook MM, Carroll JD, Eberman KM, Goldstein SA et al. Echocardiography-guided interventions. J Am Soc Echocardiogr 2009;22:213-31.
2. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002;106:3006-8. (Pubitemid 35440280)
3. Lichtenstein SV, Cheung A, Ye J, Thompson CR, Carere RG, Pasupati S et al. Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation 2006;114:591-6. (Pubitemid 44202060)
4. Grube E, Laborde JC, Zickmann B, Gerckens U, Felderhoff T, Sauren B et al. First report on a human percutaneous transluminal implantation of a self-expanding valve prosthesis for interventional treatment of aortic valve stenosis. Catheter Cardiovasc Interv 2005;66:465-9. (Pubitemid 41779008)
5. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597-607.
6. Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second-and current third-generation self-expanding corevalve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 2007;50:69-76. (Pubitemid 46970878)
7. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG et al. Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients. N Eng J Med 2011;364:2187-2198
8. Webb JG, Chandavimol M, Thompson CR, Ricci DR, Carere RG, Munt BI et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 2006;113:842-50.
9. Zajarias A, Cribier AG. Outcomes and safety of percutaneous aortic valve replacement. J Am Coll Cardiol 2009;53:1829-36.
10. Thomas M, Schymik G, Walther T, Himbert D, Lefevre T, Treede H et al. Thirtyday results of the SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2010;122:62-9.
11. Webb JG, Altwegg L, Boone RH, Cheung A, Ye J, Lichtenstein S et al. Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes. Circulation 2009;119:3009-16.
12. Lange R, Schreiber C, Gotz W, Hettich I, Will A, Libera P et al. First successful transapical aortic valve implantation with the Corevalve Revalving system: a case report. Heart Surg Forum 2007;10:E478-9.
13. Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 2008;4:242-9.
14. Vahanian A, Alfieri OR, Al-Attar N, Antunes MJ, Bax J, Cormier B et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur J Cardiothorac Surg 2008;34:1-8.
15. Osswald BR, Gegouskov V, Badowski-Zyla D, Tochtermann U, Thomas G, Hagl S et al. Overestimation of aortic valve replacement risk by EuroSCORE: implications for percutaneous valve replacement. Eur Heart J 2009;30:74-80.
16. Rodes-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Feindel CM et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 2010;55:1080-90.
17. Zegdi R, Ciobotaru V, Noghin M, Sleilaty G, Lafont A, Latrémouille C et al. Is it reasonable to treat all calcified stenotic aortic valves with a valved stent? Results from a human anatomic study in adults. J Am Coll Cardiol 2008;51:579-84.
18. Delgado V, Tops LF, Schuijf JD, van der Kley F, van de Veire NR, Schalij MJ et al. Successful deployment of a transcatheter aortic valve in bicuspid aortic stenosis: role of imaging with multislice computed tomography. Circ Cardiovasc Imaging 2009;2:e12-3.
19. Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. Eur J Echocardiogr 2009;10:1-25.
20. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD et al. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008;52: e1-142.
21. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G et al. Guidelines on the management of valvular heart disease. Eur Heart J 2007;28:230-68.
22. Grayburn PA. Assessment of low-gradient aortic stenosis with dobutamine. Circulation 2006;113:604-6.
23. Blais C, Burwash IG, Mundigler G, Dumesnil JG, Loho N, Rader F et al. Projected valve area at normal flow rate improves the assessment of stenosis severity in patients with low-flow, low-gradient aortic stenosis: the multicenter TOPAS (Truly or Pseudo-Severe Aortic Stenosis) study. Circulation 2006;113:711-21.
24. Piazza N, De Jaegere P, Schultz C, Becker AE, Serruys PW, Anderson RH. Anatomy of the aortic valvar complex and its implications for transcatheter implantation of the aortic valve. Circ Cardiovasc Interv 2008;1:74-81.
25. Vivas D, Perez de Isla L, Zamorano J. Using echocardiography to guide interventional procedures. Curr Cardiovasc Imaging Rep 2008;1:9-15.
26. Messika-Zeitoun D, Serfaty JM, Brochet E, Ducrocq G, Lepage L, Detaint D et al. Multimodal assessment of the aortic annulus diameter: implications for transcatheter aortic valve implantation. J Am Coll Cardiol 2010;55:186-94.
27. Van de Veire N. Imaging to guide transcatheter aortic valve implantation. J Echocardiogr 2010;8:1-6.
28. Spencer KT, Krauss D, Thurn J, Mor-Avi V, Poppas A, Vignon P et al. Transnasal transesophageal echocardiography. J Am Soc Echocardiogr 1997;10:728-37. (Pubitemid 127791224)
29. Spencer KT, Goldman M, Cholley B, Hultman J, Oropello J, Harris K et al. Multicenter experience using a new prototype transnasal transesophageal echocardiography probe. Echocardiography 1999;16:811-7.
30. Rallidis LS, Moyssakis IE, Ikonomidis I, Nihoyannopoulos P. Natural history of early aortic paraprosthetic regurgitation: a five-year follow-up. Am Heart J 1999;138: 351-7. (Pubitemid 29379690)
31. Detaint D, Lepage L, Himbert D, Brochet E, Messika-Zeitoun D, Iung B et al. Determinants of significant paravalvular regurgitation after transcatheter aortic valve implantation: impact of device and annulus discongruence. JACC: Cardiovasc Interv 2009;2:821-7.
32. Lancellotti P, Tribouilloy C, Hagendorff A, Moura L, Popescu BA, Agricola E et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 1: aortic and pulmonary regurgitation (native valve disease). Eur J Echocardiogr 2010;11:223-44.
33. Zoghbi WA, Chambers JB, Dumesnil JG, Foster E, Gottdiener JS, Grayburn PA et al. Recommendations for evaluation of prosthetic valves with echocardiography and Doppler ultrasound: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Task Force on Prosthetic Valves, developed in conjunction with the American College of Cardiology Cardiovascular Imaging Committee, Cardiac Imaging Committee of the American Heart Association, the European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography and the Canadian Society of Echocardiography, endorsed by the American College of Cardiology Foundation, American Heart Association, European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography, and Canadian Society of Echocardiography. J Am Soc Echocardiogr 2009;22:975-1014.
34. Gonçalves A, Marcos-Alberca P, Zamorano JL. Echocardiography: guidance during valve implantation. EuroIntervention 2010;6:g14-9.
35. Moss RR, Ivens E, Pasupati S, Humphries K, Thompson CR, Munt B et al. Role of echocardiography in percutaneous aortic valve implantation. JACC: Cardiovasc Imaging 2008;1:15-24. (Pubitemid 351445392)
36. Tuzcu EM. Transcatheter aortic valve replacement malposition and embolization: innovation brings solutions also new challenges. Catheter Cardiovasc Interv 2008;4: 579-80.
37. de Isla LP, Rodriguez E, Zamorano J. Transapical aortic prosthesis misplacement. J Am Coll Cardiol 2008;52:2043.
38. Walther T, Falk V, Kempfert J, Borger MA, Fassl J, Chu MWA et al. Transapical minimally invasive aortic valve implantation; the initial 50 patients. Eur J Cardiothorac Surg 2008;33:983-8.
39. Yan TD, Cao C, Martens-Nielsen J, Padang R, Ng M, Vallely MP et al. Transcatheter aortic valve implantation for high-risk patients with severe aortic stenosis: a systematic review. J Thorac Cardiovasc Surg 2010;139:1519-28.
40. Berry C, Cartier R, Bonan R. Fatal ischemic stroke related to nonpermissive peripheral artery access for percutaneous aortic valve replacement. Catheter Cardiovasc Interv 2007;69:56-63. (Pubitemid 46052593)
41. Masson JB, Kovac J, Schuler G, Ye J, Cheung A, Kapadia S et al. Transcatheter aortic valve implantation: review of the nature, management, and avoidance of procedural complications. JACC: Cardiovasc Interv 2009;2:811-20.
42. Bleiziffer S, Ruge H, Horer J, Hutter A, Geisbnsch S, Brockmann G et al. Predictors for new-onset complete heart block after transcatheter aortic valve implantation. JACC: Cardiovasc Interv 2010;3:524-30.
43. Unsworth B, Malik I, Mikhail GW. Recognising bicuspid aortic stenosis in patients referred for transcatheter aortic valve implantation: routine screening with threedimensional transoesophageal echocardiography. Heart 2010;96:645.
44. Shames S, Koczo A, Hahn R, Gillam L. Flow characteristics of the SAPIENTM aortic valve: the importance of recognizing in-stent flow acceleration for the echocardiographic assessment of valve function. J Am Soc Echocardiogr 2011;24: B63.
45. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and doppler echocardiography. J Am Soc Echocardiogr 2003;16:777-802. (Pubitemid 37391035)
46. Pirat B, Little SH, Igo SR, McCulloch M, Nose Y, Hartley CJ et al. Direct measurement of proximal isovelocity surface area by real-time three-dimensional color Doppler for quantitation of aortic regurgitant volume: an in vitro validation. J Am Soc Echocardiogr 2009;22:306-13.
47. Grube E, Buellesfeld L, Mueller R, Sauren B, Zickmann B, Nair D et al. Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve Revalving system. Circ Cardiovasc Interv 2008;1:167-75.
48. Webb JG, Altwegg L, Masson JB, Al Bugami S, Al Ali A, Boone RA. A new transcatheter aortic valve and percutaneous valve delivery system. J Am Coll Cardiol 2009;53:1855-8.
49. Tamburino C, Barbanti M, Capodanno D, Ussia GP. Transcatheter aortic valve implantations: what has been done and what is going to be done. Future Cardiol 2010;6:83-95.
50. Piechaud J. Percutaneous closure of mitral paravalvular leak. J Interv Cardiol 2003; 16:153-5. (Pubitemid 36529060)
51. Hijazi Z. Transcatheter management of paravalvular mitral leaks: far from ideal. Catheter Cardiovasc Interv 2004;61:552-3. (Pubitemid 38419148)
52. Nietlispach F, Johnson M, Moss RR, Wijesinghe N, Gurvitch R, Tay ELW et al. Transcatheter closure of paravalvular defects using a purpose-specific occluder. JACC: Cardiovasc Interv 2010;3:759-65.
53. Defterios S, Giannopoulos G, Raisakis K, Kaoukis K, Kossyvakis C. Intracardiac echocardiography imaging of periprosthetic valvular regurgitation. Eur J Echocardiogr 2010;11:E20.
54. Hamilton-Craig C, Boga T, Platts D,Walters DL, Burstow DJ, Scalia G. The role of 3D transesophageal echocardiography during percutaneous closure of paravalvular mitral regurgitation. JACC: Cardiovasc Imaging 2009;2:771-3.
55. Garcia-Fernandez MA, Cortes M, Garcia-Robles JA, Gomez de Diego JJ, Perez-David E, Garcia E. Utility of real-time three-dimensional transesophageal echocardiography in evaluating the success of percutaneous transcatheter closure of mitral paravalvular leaks. J Am Soc Echocardiogr 2010;23:26-32.
56. Hagler DJ, Cabalka AK, Sorajja P, Cetta F, Mankad SV, Bruce CJ et al. Assessment of percutaneous catheter treatment of paravalvular prosthetic regurgitation. J Am Coll Cardiol Imaging 2010;3:88-91.
57. Kim MS, Casserly IP, Garcia JA, Klein AJ, Salcedo EE, Carroll JD. Percutaneous transcatheter closure of prosthetic mitral paravalvular leaks: are we there yet? JACC: Cardiovasc Interv 2009;2:81-90.
58. Pate G, Thompson CR, Munt BI, Webb JG. Techniques for percutaneous closure of prosthetic paravalvular leaks. Catheter Cardiovasc Interv 2010;67: 158-66. (Pubitemid 43062624)
59. Becerra JM, Almeria C, de Isla LP, Zamorano J. Usefulness of 3D transoesophageal echocardiography for guiding wires and closure devices in mitral perivalvular leaks. Eur J Echocardiogr 2009;10:979-81.
60. Phillips SA, Thompson A, bu-Halimah A, Crenshaw MH, Zhao DX, Pretorius M. Percutaneous closure of aortic prosthetic paravalvular regurgitation with two Amplatzer septal occluders. Anesth Analg 2009;108:437-8.
61. Pate G, Al Zubaidi A, Chandavimol M, Thompson CR, Munt BI, Webb JG. Percutaneous closure of prosthetic paravalvular leaks: case series and review. Catheter Cardiovasc Interv 2006;68:528-33. (Pubitemid 44546043)
62. Sorajja P, Cabalka AK, Hagler DJ, Reeder GS, Chandrasekaran K, Cetta F et al. Successful percutaneous repair of perivalvular prosthetic regurgitation. Catheter Cardiovasc Interv 2007;70:815-23.
63. Alonso-Briales JH, Muñoz-García AJ, Jiménez-Navarro MF, Domínguez-Franco AJ, Melero-Tejedor JM, Rodríguez- Bailón I et al. Closure of perivalvular leaks using an Amplatzer occluder. Rev Esp Cardiol 2009;62:442-6.
64. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet 2006;368: 1005-11. (Pubitemid 44353666)
65. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, Levang OW et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003;24: 1231-43. (Pubitemid 36834640)
66. Mirabel M, Iung B, Baron G, Messika-Zeitoun D, Détaint D, Vanoverschelde JL et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J 2007;28:1358-65. (Pubitemid 47355974)
67. Masson JB, Webb JG. Percutaneous treatment of mitral regurgitation. Circ Cardiovasc Interv 2009;2:140-6.
68. Magne J, Pibarot P, Dagenais F, Hachicha Z, Dumesnil JG, Senechal M. Preoperative posterior leaflet angle accurately predicts outcome after restrictive mitral valve annuloplasty for ischemic mitral regurgitation. Circulation 2007; 115:782-91.
69. Tops LF, van de Veire NR, Schuijf JD, de Roos A, van der Wall EE, Schalij MJ et al. Noninvasive evaluation of coronary sinus anatomy and its relation to the mitral valve annulus: implications for percutaneous mitral annuloplasty. Circulation 2007;115:1426-32. (Pubitemid 46648378)
70. Sorajja P, Nishimura RA, Thompson J, Zehr K. A novel method of percutaneous mitral valve repair for ischemic mitral regurgitation. JACC: Cardiovasc Interv 2008;1: 663-72.
71. Alfieri O, Maisano F, De Bonis M, Stefano PL, Torracca L, Oppizzi M et al. The double-orifice technique in mitral valve repair: a simple solution for complex problems. J Thorac Cardiovasc Surg 2001;122:674-81. (Pubitemid 35470109)
72. De Bonis M, Lapenna E, La Canna G, Ficarra E, Pagliaro M, Torracca L et al. Mitral valve repair for functional mitral regurgitation in end-stage dilated cardiomyopathy: role of the 'edge-to-edge' technique. Circulation 2005; 112:I-402.
73. Feldman T, Kar S, Rinaldi M, Fail P, Hermiller J, Smalling R et al. Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol 2009;54:686-94.
74. Feldman T. Endovascular Valve Edge-to-Edge Repair study (EVEREST II) randomized clinical trial: primary safety and efficacy endpoints. Presented at American College of Cardiology Congress 2010.
75. Tamburino C, Ussia GP, Maisano F, Capodanno D, La Canna G, Scandura S et al. Percutaneous mitral valve repair with the MitraClip system: acute results from a real world setting. Eur Heart J 2010;31:1382-9.
76. Franzen O, Baldus S, Rudolph V, Meyer S, Knap M, Koschyk D et al. Acute outcomes of MitraClip therapy for mitral regurgitation in high-surgical-risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction. Eur Heart J 2010;31:1373-81.
77. Grossi EA, Patel N,Woo YJ, Goldberg JD, Schwartz CF, Subramanian V et al. Outcomes of the RESTOR-MV Trial (Randomized Evaluation of a Surgical Treatment for Off-Pump Repair of the Mitral Valve). J Am Coll Cardiol 2010;56:1984-93.
78. Silvestry FE, Rodriguez LL, Herrmann HC, Rohatgi S, Weiss SJ Stewart WJ et al. Echocardiographic guidance and assessment of percutaneous repair for mitral regurgitation with the Evalve MitraClip: lessons learned from EVEREST I. J Am Soc Echocardiogr 2007;20:1131-40. (Pubitemid 47487496)
79. Lin BA, Forouhar AS, Pahlevan NM, Anastassiou CA, Grayburn PA, Thomas JD et al. Color Doppler jet area overestimates regurgitant volume when multiple jets are present. J Am Soc Echocardiogr 2010;23: 993-1000.
80. Luigi M. Localization of mitral periprosthetic leaks by transesophageal echocardiography. AJC 1992;69:276-9.